Skip to main content

Table 11 Total costs prevented for individuals and the health systems over lifetime of the benefit cohorts

From: The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)

Benefit cohort

Direct costs for individuals prevented - medical expenses (millions)

Indirect costs for individuals prevented - lost wages (millions)

Direct costs for the health system prevented (millions)

Total costs prevented (billions)

Lifetime benefit per individual within the benefit cohorta

1. Protected from acquiring infection

$1,376

$52,513

$1,813

$55.70

$2,569

2. Subclinical morbidity prevented from progressing

$818

$31,273

$1,063

$33.2

$2,572

3. Alleviated clinical disease

$744

$10,210

$664

$11.6

$855

Total

$2,938

$93,996

$3,540

$100.5

$2,095b

  1. aDoes not include the economic benefit to the health system
  2. bWeighted average
  3. See Additional file 2: Table S4 for the results stratified by WHO region. Costs are expressed in US$ 2014 prices